FR3092755B1 - Anti-aging dermatological and cosmetic composition - Google Patents
Anti-aging dermatological and cosmetic composition Download PDFInfo
- Publication number
- FR3092755B1 FR3092755B1 FR1901584A FR1901584A FR3092755B1 FR 3092755 B1 FR3092755 B1 FR 3092755B1 FR 1901584 A FR1901584 A FR 1901584A FR 1901584 A FR1901584 A FR 1901584A FR 3092755 B1 FR3092755 B1 FR 3092755B1
- Authority
- FR
- France
- Prior art keywords
- cosmetic composition
- dermatological
- cosmetic
- aging
- animal cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/577—Malvaceae (Mallow family)
- A61K36/5777—Theobroma, e.g. cocao or cocoa
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Composition cosmétique et/ou dermatologique comprenant à titre de principe actif de la phycocyanine pour son utilisation en tant que solution à application cutanée pour lutter contre le raccourcissement de télomères de cellules animales et plus particulièrement de cellules animales d’origine humaine, le reste de la composition étant constituée par les ingrédients admissibles dans le domaine cosmétique et/ou dermatologique. Figure 1Cosmetic and/or dermatological composition comprising, as active principle, phycocyanin for its use as a solution for cutaneous application to combat the shortening of telomeres of animal cells and more particularly of animal cells of human origin, the rest of the composition consisting of ingredients acceptable in the cosmetic and/or dermatological field. Figure 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1901584A FR3092755B1 (en) | 2019-02-15 | 2019-02-15 | Anti-aging dermatological and cosmetic composition |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1901584A FR3092755B1 (en) | 2019-02-15 | 2019-02-15 | Anti-aging dermatological and cosmetic composition |
| FR1901584 | 2019-02-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3092755A1 FR3092755A1 (en) | 2020-08-21 |
| FR3092755B1 true FR3092755B1 (en) | 2021-11-19 |
Family
ID=67999712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1901584A Active FR3092755B1 (en) | 2019-02-15 | 2019-02-15 | Anti-aging dermatological and cosmetic composition |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR3092755B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117323242A (en) * | 2022-06-25 | 2024-01-02 | 上海春芝堂生物制品有限公司 | Fluorine-containing refreshing essence and film-making method thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8906361B2 (en) | 2011-03-28 | 2014-12-09 | John V. Cappello | Anti-aging formulations |
| EP3120830A1 (en) * | 2015-07-21 | 2017-01-25 | Greenaltech, S.L. | Compositions for protecting skin comprising dna repair enzymes and phycobiliprotein |
| CN107308068A (en) * | 2017-01-19 | 2017-11-03 | 北京柯瑞生物科技有限公司 | A kind of face cream of the extract containing Spirullina |
| KR20190005369A (en) * | 2017-07-06 | 2019-01-16 | 한국 한의학 연구원 | Composition for preventing or improving skin wrinkle comprising c-phycocyanin as effective component |
| CN107334724A (en) * | 2017-08-07 | 2017-11-10 | 广州赛莱拉干细胞科技股份有限公司 | A kind of anti-ageing face mask of the stem cell containing matrimony vine and preparation method thereof |
-
2019
- 2019-02-15 FR FR1901584A patent/FR3092755B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR3092755A1 (en) | 2020-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR3066388B1 (en) | COSMETIC COMPOSITION COMPRISING ROSE EXTRACTS | |
| CL2019003586A1 (en) | Compositions and methods for internalizing enzymes. | |
| BR112015006828A8 (en) | compound, or a pharmaceutically acceptable salt thereof; pharmaceutical composition; use of the compound; and method for modulating the activity of an ire1 protein | |
| EA201890516A1 (en) | CLINICAL COMPOSITIONS | |
| MX376139B (en) | KERATIN TREATMENT FORMULATIONS AND METHODS. | |
| AR094740A1 (en) | ANTIADHESION OF LEUKOCYTES TO MITIGATE POTENTIAL ADVERSE EVENTS CAUSED BY CD3 SPECIFIC UNION DOMAINS | |
| BR112012015446A2 (en) | stimulating compositions of paxillin and cosmetic uses thereof | |
| DE602005013422D1 (en) | FORMULATIONS WITH CERAMIDES AND / OR PSEUDOCERAMIDES AND (ALPHA-) BISABOLOL FOR THE TREATMENT OF SKIN DAMAGE | |
| EA201800591A1 (en) | MICROCAPSULES CONTAINING LIVING MICROORGANISMS AND THEIR APPLICATION | |
| CO6761392A2 (en) | Protein administration from stem cell microcarriers | |
| CL2022001655A1 (en) | Engineered variants of acid alpha-glucosidase. | |
| CA2983434C (en) | NKT CELL SUBSET FOR IN VIVO PERSISTENCE AND THERAPEUTIC ACTIVITY AND PROPAGATION | |
| FR2939040B1 (en) | ASSOCIATION OF LYCOPENE, POLYPHENOL AND VITAMINS FOR THE CARE OF KERATINIC MATTER | |
| BR112015022154A2 (en) | combinations of active substances, cosmetic or dermatological preparations, cosmetic use, and combinations of active substances and preparations | |
| BR112013016935A2 (en) | skin dynein modulation | |
| BR112023002926A2 (en) | INHALABLE THERAPEUTIC AGENTS | |
| BRPI0412989A (en) | pharmaceutical combination useful for stem cell mobilization | |
| FR3092755B1 (en) | Anti-aging dermatological and cosmetic composition | |
| EA202191780A1 (en) | COSMETIC / DERMATOLOGICAL COMPOSITION | |
| FR3115691B1 (en) | Skin care composition | |
| BR112022010976A2 (en) | ORAL PRODUCTS WITH CONTROLLED RELEASE | |
| BR112021019139A2 (en) | Engineered mammalian cell, composition, isolated double-stranded DNA molecule, implantable device, hydrogel capsule, and method of treating a patient with Fabry disease | |
| EA202092077A1 (en) | LOCAL COMPOSITIONS CONTAINING STRONZIUM AND METHYLSULPHONYLMETHANE (MSM) AND METHODS OF TREATMENT | |
| CY1106227T1 (en) | COMPOSITION FOR FACILITATING HUMAN BIRTH | |
| BR112022003358A2 (en) | Compound, pharmaceutical composition, method of inhibiting glycolate oxidase (gox) activity in a biological sample, method of treating an oxalate-related disease in an individual in need thereof, and use of a compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 2 |
|
| PLSC | Publication of the preliminary search report |
Effective date: 20200821 |
|
| PLFP | Fee payment |
Year of fee payment: 3 |
|
| PLFP | Fee payment |
Year of fee payment: 4 |
|
| PLFP | Fee payment |
Year of fee payment: 5 |
|
| PLFP | Fee payment |
Year of fee payment: 6 |
|
| PLFP | Fee payment |
Year of fee payment: 7 |